92 related articles for article (PubMed ID: 34655923)
1. REV3L single nucleotide variants lead to increased susceptibility towards non-small cell lung cancer in the population of Jammu and Kashmir.
Jamwal RS; Mahajan N; Bhat GR; Bhat A; Shah R; Verma S; Sharma M; Sharma B; Qadri RA; Kumar R; Bhat A
Cancer Epidemiol; 2021 Dec; 75():102047. PubMed ID: 34655923
[TBL] [Abstract][Full Text] [Related]
2. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA‑29a enhances cisplatin sensitivity in non‑small cell lung cancer through the regulation of REV3L.
Chen X; Zhu H; Ye W; Cui Y; Chen M
Mol Med Rep; 2019 Feb; 19(2):831-840. PubMed ID: 30535450
[TBL] [Abstract][Full Text] [Related]
4. REV3L modulates cisplatin sensitivity of non-small cell lung cancer H1299 cells.
Wang W; Sheng W; Yu C; Cao J; Zhou J; Wu J; Zhang H; Zhang S
Oncol Rep; 2015 Sep; 34(3):1460-8. PubMed ID: 26165320
[TBL] [Abstract][Full Text] [Related]
5. Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India.
Bhat GR; Bhat A; Verma S; Sethi I; Shah R; Sharma V; Dar KA; Abrol D; Kaneez S; Kaul S; Ganju R; Kumar R
BMC Cancer; 2019 May; 19(1):493. PubMed ID: 31126249
[TBL] [Abstract][Full Text] [Related]
6. Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India.
Bhat GR; Jamwal RS; Sethi I; Bhat A; Shah R; Verma S; Sharma M; Sadida HQ; Al-Marzooqi SK; Masoodi T; Mirza S; Haris M; Macha MA; Akil ASA; Bhat AA; Kumar R
BMC Cancer; 2023 Sep; 23(1):874. PubMed ID: 37718447
[TBL] [Abstract][Full Text] [Related]
7. Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients.
Agulló-Ortuño MT; García-Ruiz I; Díaz-García CV; Enguita AB; Pardo-Marqués V; Prieto-García E; Ponce S; Iglesias L; Zugazagoitia J; López-Martín JA; Paz-Ares L; Nuñez JA
Cancer Chemother Pharmacol; 2020 Mar; 85(3):525-535. PubMed ID: 31832811
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in translesion polymerase genes influence treatment outcome in malignant mesothelioma.
Goričar K; Kovač V; Dolžan V
Pharmacogenomics; 2014 May; 15(7):941-50. PubMed ID: 24956248
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.
Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2011 Aug; 129(1):235-45. PubMed ID: 21455670
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA PRMT5 confers cisplatin-resistance via miR-4458/REV3L axis in non-small-cell lung cancer.
Pang J; Ye L; Zhao D; Zhao D; Chen Q
Cell Biol Int; 2020 Dec; 44(12):2416-2426. PubMed ID: 32808744
[TBL] [Abstract][Full Text] [Related]
11. ATM sequence variants associate with susceptibility to non-small cell lung cancer.
Yang H; Spitz MR; Stewart DJ; Lu C; Gorlov IP; Wu X
Int J Cancer; 2007 Nov; 121(10):2254-9. PubMed ID: 17582598
[TBL] [Abstract][Full Text] [Related]
12. Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians.
Bhat GR; Sethi I; Bhat A; Verma S; Bakshi D; Sharma B; Nazir M; Dar KA; Abrol D; Shah R; Kumar R
Sci Rep; 2021 May; 11(1):11291. PubMed ID: 34050209
[TBL] [Abstract][Full Text] [Related]
13. Genetic association of ARID5B with the risk of colorectal cancer within Jammu and Kashmir, India.
Sharma B; Angurana S; Shah R; Verma S; Bhat A; Bhat GR; Bakshi D; Jamwal RS; Tanwar M; Singh S; Bhat A; Vaishnavi S; Kumar R
Genes Genet Syst; 2021 Dec; 96(4):187-191. PubMed ID: 34803080
[TBL] [Abstract][Full Text] [Related]
14. CYP3A4 genetic variants are associated with susceptibility of non-small cell lung cancer in a Shaanxi Han population.
Jia Z; Zhou W; Zhang G; Fu J; Li D; Ren L
Genomics; 2020 Sep; 112(5):3465-3472. PubMed ID: 32464168
[TBL] [Abstract][Full Text] [Related]
15. Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.
Xing YL; Liu F; Li JF; Lin JC; Zhu GD; Li M; Zhang CR; Niu YY
J Clin Lab Anal; 2016 Nov; 30(6):1071-1077. PubMed ID: 27154632
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms and haplotypes in the XRCC1 gene and the risk of advanced non-small cell lung cancer.
Kim IS; Lee GW; Kim DC; Kim HG; Kim S; Oh SY; Kim SH; Kwon HC
J Thorac Oncol; 2010 Dec; 5(12):1912-21. PubMed ID: 20978448
[TBL] [Abstract][Full Text] [Related]
17. Association of ARID5B and IKZF1 Variants with Leukemia from Northern India.
Bhat A; Shah R; Bhat GR; Verma S; Sharma V; Sharma I; Pandita M; Bakshi D; Sharma B; Suri J; Kumar R
Genet Test Mol Biomarkers; 2019 Mar; 23(3):176-179. PubMed ID: 30810385
[TBL] [Abstract][Full Text] [Related]
18. Genetic analysis of colorectal carcinoma using high throughput single nucleotide polymorphism genotyping technique within the population of Jammu and Kashmir.
Sharma B; Angurana S; Bhat A; Verma S; Bakshi D; Bhat GR; Jamwal RS; Amin A; Qadri RA; Shah R; Kumar R
Mol Biol Rep; 2021 Aug; 48(8):5889-5895. PubMed ID: 34319543
[TBL] [Abstract][Full Text] [Related]
19.
Chaszczewska-Markowska M; Kosacka M; Chryplewicz A; Dyła T; Brzecka A; Bogunia-Kubik K
Anticancer Res; 2019 Jun; 39(6):3269-3272. PubMed ID: 31177178
[TBL] [Abstract][Full Text] [Related]
20. REV3L, the catalytic subunit of DNA polymerase ζ, is involved in the progression and chemoresistance of esophageal squamous cell carcinoma.
Zhu X; Zou S; Zhou J; Zhu H; Zhang S; Shang Z; Ding WQ; Wu J; Chen Y
Oncol Rep; 2016 Mar; 35(3):1664-70. PubMed ID: 26752104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
